| MYBL2 |
MYBL2, BMYB: Myb-related protein B |
UBTF |
UBTF, UBF, UBF1: Nucleolar transcription factor 1 |
0.36 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
SPEN |
SPEN, KIAA0929, MINT, SHARP: Msx2-interacting protein |
0.36 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
CHD4 |
CHD4: Chromodomain-helicase-DNA-binding protein 4 |
0.36 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
WRN |
WRN, RECQ3, RECQL2: Werner syndrome ATP-dependent helicase |
0.36 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
TRIM28 |
TRIM28, KAP1, RNF96, TIF1B: Transcription intermediary factor 1-beta |
0.36 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
BLM |
BLM, RECQ2, RECQL3: Bloom syndrome protein |
0.36 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
HMGB2 |
HMGB2, HMG2: High mobility group protein B2 |
0.36 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
LAMB1 |
LAMB1: Laminin subunit beta-1 precursor |
0.36 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
C3 |
|
0.36 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
ADAMTS1 |
ADAMTS1, KIAA1346, METH1: ADAMTS-1 precursor |
0.36 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
FSTL1 |
FSTL1, FRP: Follistatin-related protein 1 precursor |
0.36 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
IGFBP5 |
IGFBP5, IBP5: Insulin-like growth factor-binding protein 5 precursor |
0.36 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
LAMC1 |
LAMC1, LAMB2: Laminin subunit gamma-1 precursor |
0.36 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
TBK1 |
TBK1, NAK: Serine/threonine-protein kinase TBK1 |
0.36 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
MAP3K11 |
MAP3K11, MLK3, PTK1, SPRK: Mitogen-activated protein kinase kinase kinase 11 |
0.36 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
NCF4 |
NCF4, SH3PXD4: Neutrophil cytosol factor 4 |
0.36 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
0.36 |
Evidence |
|
| CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
CD28 |
CD28: T-cell-specific surface glycoprotein CD28 precursor |
0.36 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
CD47 |
CD47, MER6: Leukocyte surface antigen CD47 precursor |
0.36 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
ITGA4 |
ITGA4, CD49D: Integrin alpha-4 precursor |
0.36 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
ICAM2 |
ICAM2: Intercellular adhesion molecule 2 precursor |
0.36 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
0.36 |
Evidence |
|
| SPARC |
SPARC, ON: SPARC precursor |
CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
0.36 |
Evidence |
|
| LGALS1 |
LGALS1: Galectin-1 |
COL16A1 |
COL16A1: Collagen alpha-1(XVI) chain precursor |
0.36 |
Evidence |
|
| LGALS1 |
LGALS1: Galectin-1 |
PCOLCE |
PCOLCE, PCPE1: Procollagen C-endopeptidase enhancer 1 precursor |
0.36 |
Evidence |
|